These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21296606)

  • 1. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond gastric emptying: a "toxic" lesson about gastroparesis.
    Pasricha PJ
    Am J Gastroenterol; 2008 Feb; 103(2):424-6. PubMed ID: 18289204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
    Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
    Kulaksizoglu H; Parman Y
    Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder.
    Giannantoni A; Conte A; Proietti S; Giovannozzi S; Rossi A; Fabbrini G; Porena M; Berardelli A
    J Urol; 2011 Sep; 186(3):960-4. PubMed ID: 21791351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease.
    Triadafilopoulos G; Gandhy R; Barlow C
    Parkinsonism Relat Disord; 2017 Nov; 44():33-37. PubMed ID: 28847681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio.
    Espay AJ; Vaughan JE; Shukla R; Gartner M; Sahay A; Revilla FJ; Duker AP
    Mov Disord; 2011 Apr; 26(5):913-4. PubMed ID: 21432906
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
    Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of gastroparesis following total esophagectomy using botulinum toxin.
    Tcherniak A; Kashtan DH; Melzer E
    Endoscopy; 2006 Feb; 38(2):196. PubMed ID: 16479431
    [No Abstract]   [Full Text] [Related]  

  • 14. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
    Cadeddu F; Bentivoglio AR; Brandara F; Marniga G; Brisinda G; Maria G
    Aliment Pharmacol Ther; 2005 Nov; 22(10):997-1003. PubMed ID: 16268975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
    Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary herb extract rikkunshi-to ameliorates gastroparesis in Parkinson's disease: a pilot study.
    Doi H; Sakakibara R; Sato M; Hirai S; Masaka T; Kishi M; Tsuyusaki Y; Tateno A; Tateno F; Takahashi O; Ogata T
    Eur Neurol; 2014; 71(3-4):193-5. PubMed ID: 24457529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence.
    Molloy L
    Curr Opin Neurol; 2007 Aug; 20(4):493-8. PubMed ID: 17620887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Digestive disorders in Parkinson's disease: gastric atony, malabsorption and constipation].
    Pérez-Macho L; Borja-Andrés S
    Rev Neurol; 2010 Feb; 50 Suppl 2():S55-8. PubMed ID: 20205143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.